2018 Advances in Quantum Computing, Drug Delivery, and Investigational Therapies for Diabetes and Other Disorders - ResearchAndMarkets.com

January 9, 2019

DUBLIN--(BUSINESS WIRE)--Jan 9, 2019--The “Latest Advances in Quantum Computing, Drug Delivery, and Investigational Therapies for Diabetes and Other Disorders” report has been added to ResearchAndMarkets.com’s offering.

The Life Science, Health & Wellness TOE depicts the current landscape and the new life sciences trends across twelve groundbreaking drug discovery and genetic platforms.

Each and every platform is accurately profiled covering the most cutting-edge technologies energizing the pharmaceutical landscape, such as quantum computing in life sciences, innovations in drug delivery, and novel investigational therapies for diabetes and other disorders.

Topics Covered

1. Growth Opportunities in Life Sciences - Health & Wellness

Exploring the Potential of Novel Platforms in Life Sciences Diamond Solutions for Nanoscale Imaging Quantum Sequencing Technology Quantum Machine Learning for Gene Regulation High-throughput Quantum Mechanics for Drug Discovery Preclinical Promise of JAK1 Inhibitor Drug for Asthma Clinical Study of a Gene Silencing Drug for Hepatitis B Infection Stem Cell-derived Replacement Therapy for Diabetes 510(k) Clearance for gammaCore for Prevention of Cluster Headaches Nanoparticle Delivery to Improve Osteoarthritis Regenerative Therapies Thymocyte Signaling Mechanism Discovery and Autoimmune Disorders Phase 3 Success of TALICIA for Helicobacter Pylori Infection Real-time Tumor Imaging Agent from Scorpion Venom

2. Industry Relations

Regional Practice Leaders and Innovation Experts

For more information about this report visit https://www.researchandmarkets.com/research/khd8lx/2018_advances_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005371/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Computing,Drug Delivery,Diabetes Devices ,Diabetes Drugs



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/09/2019 06:32 AM/DISC: 01/09/2019 06:32 AM


Update hourly